Literature DB >> 17204025

Reporting colorectal cancer.

P Quirke1, E Morris.   

Abstract

The management of colorectal cancer is a team process. High-quality reporting of colorectal cancer is very important as the whole team relies upon the skill of the pathologist. Failure to report key features can lead to undertreatment of this disease. The use of a proforma has been demonstrated to be beneficial and we recommend staying with TNM5 due to scientific and reproducibility issues with TNM6. Important features in stage II/Dukes' B cases are extramural vascular invasion, peritoneal involvement, extent of extramural spread, incomplete resection and perforation. All of these may lead to adjuvant therapy being administered. The surgically created circumferential resection margin (CRM) and the mode of its creation are important features and the CRM retains its value after preoperative therapy. Regression grading should be applied only to fully resected tumours and the dissection and sampling must be standardized to allow comparison of results between trials and centres. When reporting local resections of early-stage cancers we need to look for features that predict spread to local lymph nodes to allow a full resection to be considered.

Entities:  

Mesh:

Year:  2007        PMID: 17204025     DOI: 10.1111/j.1365-2559.2006.02543.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  48 in total

1.  Colorectal Cancer OncoGuia: surgical pathology report guidelines.

Authors:  Xavier Sanjuán; Antonio Salas; Josep Lloreta; Paula Manchon Walsh
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

2.  Invited commentary on "Yun HR, Kim HC, Kim SH et al. (2010) Cytokeratin staining for complete remission in rectal cancer after chemoradiation. Int J Colorect Dis.

Authors:  Paul Hermanek
Journal:  Int J Colorectal Dis       Date:  2010-06-09       Impact factor: 2.571

3.  Comments on the reporting of lymph nodes and tumour budding in the checklist of colorectal carcinoma.

Authors:  Paolo Greco; Gaetano Magro
Journal:  Virchows Arch       Date:  2007-01-30       Impact factor: 4.064

4.  Extended lymphadenectomy in colon cancer is crucial.

Authors:  Hermann Kessler; Werner Hohenberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

5.  Long-term outcome of extralevator abdominoperineal excision (ELAPE) for low rectal cancer.

Authors:  Sigmar Stelzner; Gunter Hellmich; Anja Sims; Thomas Kittner; Eric Puffer; Joerg Zimmer; Dorothea Bleyl; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2016-09-09       Impact factor: 2.571

6.  Transanal Total Mesorectal Excision for Treatment of Carcinoma in the Middle or Lower Third Rectum: the Technical Feasibility of the Procedure, Pathological Results, and Clinical Outcome.

Authors:  Ashraf M Abdelkader; Ahmed M Zidan; Mohamed T Younis; Shaimaa K Dawa
Journal:  Indian J Surg Oncol       Date:  2018-08-04

7.  Obesity was associated with a decreased postoperative recurrence of rectal cancer in a Japanese population.

Authors:  Ryo Seishima; Koji Okabayashi; Hirotoshi Hasegawa; Daisuke Sugiyama; Yoshiyuki Ishii; Masashi Tsuruta; Toru Takebayashi; Yuko Kitagawa
Journal:  Surg Today       Date:  2014-05-21       Impact factor: 2.549

8.  Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer.

Authors:  M Chand; R I Swift; I Chau; R J Heald; P P Tekkis; G Brown
Journal:  Ann R Coll Surg Engl       Date:  2014-10       Impact factor: 1.891

Review 9.  The ins and outs of molecular pathology reporting.

Authors:  Véronique Tack; Kelly Dufraing; Zandra C Deans; Han J van Krieken; Elisabeth M C Dequeker
Journal:  Virchows Arch       Date:  2017-03-26       Impact factor: 4.064

10.  Evaluation of quality indicators following implementation of total mesorectal excision in primarily resected rectal cancer changed future management.

Authors:  Paul M Schneider; Daniel Vallbohmer; Yvonne Ploenes; Georg Lurje; Ralf Metzger; Frederike C Ling; Jan Brabender; Uta Drebber; Arnulf H Hoelscher
Journal:  Int J Colorectal Dis       Date:  2011-02-22       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.